C163H145F3N26O19 — CID 163469682
2,2-difluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;1-fluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;2-morpholin-4-yl-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]acetamide;bis(N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropanecarboxamide);N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]pyrimidin-2-yl]cyclopropanecarboxamide (PubChem CID 163469682) has the molecular formula C163H145F3N26O19 and a molecular weight of 2829.11 g/mol. Its IUPAC name is 2,2-difluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;1-fluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;2-morpholin-4-yl-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]acetamide;bis(N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropanecarboxamide);N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]pyrimidin-2-yl]cyclopropanecarboxamide.
| Compound Name | 2,2-difluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;1-fluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;2-morpholin-4-yl-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]acetamide;bis(N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropanecarboxamide);N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]pyrimidin-2-yl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 163469682 |
| Molecular Formula | C163H145F3N26O19 |
| Molecular Weight | 2829.11 g/mol |
| Exact Mass | 2827.11 |
| IUPAC Name | 2,2-difluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;1-fluoro-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropane-1-carboxamide;2-morpholin-4-yl-N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]acetamide;bis(N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]-2-pyridinyl]cyclopropanecarboxamide);N-[4-[[3-(5-phenyl-1H-imidazol-2-yl)-3,4-dihydro-2H-chromen-6-yl]oxy]pyrimidin-2-yl]cyclopropanecarboxamide |
| SMILES | O=C(CN1CCOCC1)Nc1cc(Oc2ccc3c(c2)CC(c2ncc(-c4ccccc4)[nH]2)CO3)ccn1.O=C(Nc1cc(Oc2ccc3c(c2)CC(c2ncc(-c4ccccc4)[nH]2)CO3)ccn1)C1(F)CC1.O=C(Nc1cc(Oc2ccc3c(c2)CC(c2ncc(-c4ccccc4)[nH]2)CO3)ccn1)C1CC1.O=C(Nc1cc(Oc2ccc3c(c2)CC(c2ncc(-c4ccccc4)[nH]2)CO3)ccn1)C1CC1.O=C(Nc1cc(Oc2ccc3c(c2)CC(c2ncc(-c4ccccc4)[nH]2)CO3)ccn1)C1CC1(F)F.O=C(Nc1nccc(Oc2ccc3c(c2)CC(c2ncc(-c4ccccc4)[nH]2)CO3)n1)C1CC1 |
| InChI | InChI=1S/C29H29N5O4.C27H22F2N4O3.C27H23FN4O3.2C27H24N4O3.C26H23N5O3/c35-28(18-34-10-12-36-13-11-34)33-27-16-24(8-9-30-27)38-23-6-7-26-21(15-23)14-22(19-37-26)29-31-17-25(32-29)20-4-2-1-3-5-20;28-27(29)13-21(27)26(34)33-24-12-20(8-9-30-24)36-19-6-7-23-17(11-19)10-18(15-35-23)25-31-14-22(32-25)16-4-2-1-3-5-16;28-27(9-10-27)26(33)32-24-14-21(8-11-29-24)35-20-6-7-23-18(13-20)12-19(16-34-23)25-30-15-22(31-25)17-4-2-1-3-5-17;2*32-27(18-6-7-18)31-25-14-22(10-11-28-25)34-21-8-9-24-19(13-21)12-20(16-33-24)26-29-15-23(30-26)17-4-2-1-3-5-17;32-25(17-6-7-17)31-26-27-11-10-23(30-26)34-20-8-9-22-18(13-20)12-19(15-33-22)24-28-14-21(29-24)16-4-2-1-3-5-16/h1-9,15-17,22H,10-14,18-19H2,(H,31,32)(H,30,33,35);1-9,11-12,14,18,21H,10,13,15H2,(H,31,32)(H,30,33,34);1-8,11,13-15,19H,9-10,12,16H2,(H,30,31)(H,29,32,33);2*1-5,8-11,13-15,18,20H,6-7,12,16H2,(H,29,30)(H,28,31,32);1-5,8-11,13-14,17,19H,6-7,12,15H2,(H,28,29)(H,27,30,31,32) |
| InChIKey | BVNLQTLRTJDLDV-UHFFFAOYSA-N |
| XLogP | 30.64 |
| TPSA | 560.14 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 211 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2829.11 |
| LogP ≤ 5 | 30.64 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 33 |